{"transactions":[{"id":932462,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-23T18:12:03.000Z","date":"2026-01-22","kind":"sale","planned":false,"acquired":false,"shares":895,"price":1.82,"value":1628.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."}],"balance_after":255371,"source":{"system":"sec-edgar","filing":"0001628280-26-003348","document":"wk-form4_1769209918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026003348/wk-form4_1769209918.xml","form_type":"4"}},{"id":932461,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-23T18:12:03.000Z","date":"2026-01-21","kind":"sale","planned":false,"acquired":false,"shares":2331,"price":1.8035,"value":4203.9585,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7600 to $1.8700. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":256266,"source":{"system":"sec-edgar","filing":"0001628280-26-003348","document":"wk-form4_1769209918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026003348/wk-form4_1769209918.xml","form_type":"4"}},{"id":934374,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-21T18:31:11.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":148700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":148700,"derivative":{"exercise_price":1.89,"expiration_date":"2036-01-16","underlying":"Common Stock","underlying_shares":148700},"source":{"system":"sec-edgar","filing":"0001628280-26-002959","document":"wk-form4_1769038268.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026002959/wk-form4_1769038268.xml","form_type":"4"}},{"id":934373,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-21T18:31:11.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":99133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":258597,"source":{"system":"sec-edgar","filing":"0001628280-26-002959","document":"wk-form4_1769038268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026002959/wk-form4_1769038268.xml","form_type":"4"}},{"id":944727,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:31.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":6834,"price":1.967,"value":13442.478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":159464,"source":{"system":"sec-edgar","filing":"0001628280-26-001264","document":"wk-form4_1767839485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026001264/wk-form4_1767839485.xml","form_type":"4"}},{"id":944726,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-07T21:31:31.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":4000,"price":1.9587,"value":7834.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":166298,"source":{"system":"sec-edgar","filing":"0001628280-26-001264","document":"wk-form4_1767839485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000162828026001264/wk-form4_1767839485.xml","form_type":"4"}},{"id":1296506,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-23T17:06:50.000Z","date":"2025-01-21","kind":"sale","planned":true,"acquired":false,"shares":3219,"price":1.59,"value":5118.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."}],"balance_after":170298,"source":{"system":"sec-edgar","filing":"0001576885-25-000029","document":"wk-form4_1737670003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688525000029/wk-form4_1737670003.xml","form_type":"4"}},{"id":1308275,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-07T19:48:53.000Z","date":"2025-01-06","kind":"grant","planned":true,"acquired":true,"shares":100300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":100300,"derivative":{"exercise_price":1.85,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":100300},"source":{"system":"sec-edgar","filing":"0001576885-25-000009","document":"wk-form4_1736297327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688525000009/wk-form4_1736297327.xml","form_type":"4"}},{"id":1308274,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-07T19:48:53.000Z","date":"2025-01-06","kind":"grant","planned":true,"acquired":true,"shares":66800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":173517,"source":{"system":"sec-edgar","filing":"0001576885-25-000009","document":"wk-form4_1736297327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688525000009/wk-form4_1736297327.xml","form_type":"4"}},{"id":1308273,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-01-07T19:48:53.000Z","date":"2025-01-03","kind":"sale","planned":true,"acquired":false,"shares":10859,"price":1.8461,"value":20046.7999,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 3, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.7750 to $1.9100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":106717,"source":{"system":"sec-edgar","filing":"0001576885-25-000009","document":"wk-form4_1736297327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688525000009/wk-form4_1736297327.xml","form_type":"4"}},{"id":1675397,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-19T19:05:14.000Z","date":"2024-01-18","kind":"sale","planned":true,"acquired":false,"shares":3124,"price":3.7144,"value":11603.7856,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person through an automatic \"sell to cover\" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units (\"RSUs\") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.7103 and $3.7150. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":117576,"source":{"system":"sec-edgar","filing":"0001576885-24-000025","document":"wk-form4_1705709102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688524000025/wk-form4_1705709102.xml","form_type":"4"}},{"id":1688298,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-04T16:21:26.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":141000,"derivative":{"exercise_price":4.23,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0001576885-24-000011","document":"wk-form4_1704403255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688524000011/wk-form4_1704403255.xml","form_type":"4"}},{"id":1688297,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-04T16:21:26.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":120700,"source":{"system":"sec-edgar","filing":"0001576885-24-000011","document":"wk-form4_1704403255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000157688524000011/wk-form4_1704403255.xml","form_type":"4"}},{"id":2052752,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-18T16:23:49.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":120200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":120200,"derivative":{"exercise_price":6.11,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":120200},"source":{"system":"sec-edgar","filing":"0001209191-23-003745","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000120919123003745/doc4.xml","form_type":"4"}},{"id":2052751,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-18T16:23:49.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":26700,"source":{"system":"sec-edgar","filing":"0001209191-23-003745","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000120919123003745/doc4.xml","form_type":"4"}},{"id":2428866,"issuer":{"id":6281,"kind":"organization","name":"Acumen Pharmaceuticals, Inc."},"owners":[{"id":68913,"kind":"person","name":"Siemers Eric","position":1,"cik":"0001866239","reported_name":"Siemers Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-01-21T16:21:25.000Z","date":"2022-01-19","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on January 19, 2023, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date."}],"balance_after":90000,"derivative":{"exercise_price":5.19,"expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-004423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866239/000120919122004423/doc4.xml","form_type":"4"}}]}